DNA methylation in polymyalgia rheumatica
Part of Bones, joints & muscles, Skin clinical trials.
This study looks at blood markers related to DNA changes in people with polymyalgia rheumatica (PMR). It aims to better understand the condition and may help guide future treatments.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 50 and 89 years old.
- You must have a diagnosis of polymyalgia rheumatica (PMR).
- You must be taking at least 10 mg of prednisone (or an equivalent steroid) at the time of joining.
- Your blood tests must show normal levels of inflammation markers (CRP and ESR).
- You must not have other rheumatic diseases (like lupus or arthritis), active cancer, an infection, or have had surgery in the past 6 months.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a blood test for a protein called thrombomodulin can help rule out giant cell arteritis (a blood vessel inflammation) in people with polymyalgia rheumatica. It involves a blood draw and a one-time imaging scan to look at your blood vessels.
This trial tests if new imaging methods can help diagnose and treat polymyalgia rheumatica (PMR). It may be for you if you're over 50, have pain in your shoulders or hips, and haven't taken steroids for PMR in the last 2 months.
This study looks at people newly diagnosed with polymyalgia rheumatica (PMR) or giant cell arteritis (GCA) and uses their health and treatment information to learn what predicts how well treatment works. It may help your care in the future by improving which patients respond best and how.
This study tests a personalized rehabilitation program to help people with polymyalgia rheumatica (PMR) become more active and reduce disease symptoms. It aims to see if tailored exercise can improve your condition and daily life.
This trial tests if adding baricitinib (a pill that calms inflammation) to standard steroids works better than steroids alone for people with polymyalgia rheumatica. It aims to improve symptoms and reduce steroid side effects.
This study is for people with certain rheumatic conditions (like arthritis, lupus, or vasculitis) and for healthy volunteers. It aims to learn more about these diseases and improve how they are treated.
Hear when a new Polymyalgia Rheumatica (PMR) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.